Suzhou, China · Founded 2014 · In IPO Registration
Developer of original anti-tumor drugs designed for anti-cancer therapeutics. Gen House is based in Suzhou, China and was founded in 2014. Its last reported valuation was $268 million in Jan 2026. It has raised $121 million.
Last reported valuation
$268.3M
Oct 2026
Priced at
—
Total raised
$120.5M
Last round
—
Cap table — not yet on record
Gen House's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Gen House with a free account
·The complete investor list: 23 names
·Watch Gen House: the Monday email on marks, rounds and moves
